论文部分内容阅读
目的:探讨经尿道前列腺汽化电切术治疗前列腺增生症(BPH)的优越性。方法:对162例前列腺增生症采用经尿道汽化切割(TUVP)并用前列腺电切术(TURP)治疗。结果:162例良性前列腺增生症患者中,89例术后获随访0.6~4年,平均12.3个月。国际前列腺症状积分(IPSS)由术前24.7±7.2下降至9.2±2.5;生活质量评分(QOL)由5.2±0.6降至1.5±0.6;残余尿量由(150.3±52.0)mL减少至(21.3±12.3)mL。最大尿流率由(6.6±1.3)mL/s增加至(33.2±3.2)mL/s,平均尿流率由(4.1±0.9)mL/s增大至(10.1±1.6)mL/s。上述指标术前术后相比有显著性差异(P<0.05)。结论:TUVP结合TURP治疗前列腺增生症较开放手术具有适应症宽、痛苦少、出血少、恢复快、并发症少、疗效显著等优点。
Objective: To investigate the superiority of transurethral vaporization of the prostate in the treatment of benign prostatic hyperplasia (BPH). Methods: 162 cases of benign prostatic hyperplasia by transurethral vaporization (TUVP) and prostatectomy (TURP) treatment. Results: Of 162 patients with benign prostatic hyperplasia, 89 patients were followed up for 0.6-6 years with an average of 12.3 months. The International Prostate Symptom Score (IPSS) decreased from 24.7 ± 7.2 to 9.2 ± 2.5 preoperatively, the QOL decreased from 5.2 ± 0.6 to 1.5 ± 0.6, and the residual urine volume decreased from 150.3 ± 52.0 mL to 21.3 ± 12.3) mL. The maximum urinary flow rate increased from (6.6 ± 1.3) mL / s to (33.2 ± 3.2) mL / s and the mean urinary flow rate increased from (4.1 ± 0.9) mL / s to (10.1 ± 1.6) mL / s. The above indexes were significantly different before and after operation (P <0.05). Conclusion: TUVP combined with TURP in the treatment of benign prostatic hyperplasia than the open surgery with indications wide, less pain, less bleeding, rapid recovery, fewer complications, significant effect and so on.